# Acrivon AB

**Source:** https://www.startuphub.ai/startups/acrivon-ab
**Profile type:** Startup

## About

Acrivon AB develops targeted therapies for cancer patients by matching drug mechanisms to the biologic drivers of cancer using their proprietary AP3 platform. This platform uncovers drug sensitivity not achievable through genomics, enabling them to improve patient outcomes with their pipeline programs, including ACR-368, ACR-2316, and ACR-6840. Acrivon also partners with other companies to develop predictive OncoSignature tests for drug candidates.

## Key facts

- **Slug:** acrivon-ab
- **Website:** https://www.acrivon.com/
- **Location:** Uppsala, Sweden
- **Founded:** 2022-01-01
- **Operating status:** Active
- **Total funding:** $10M
- **Sectors / tags:** AI Tools & Apps, AI Drug Discovery, Biotech, HealthTech, Foundation Model, Generative AI, Drug Discovery, Therapeutics

## Frequently asked

### What does Acrivon AB do?

Acrivon AB develops targeted therapies for cancer patients by matching drug mechanisms to the biologic drivers of cancer using their proprietary AP3 platform. This platform uncovers drug sensitivity not achievable through genomics, enabling them to improve patient outcomes with their pipeline programs, including ACR-368, ACR-2316, and ACR-6840. Acrivon also partners with other companies to develop predictive OncoSignature tests for drug candidates.

### What is Acrivon AB's revenue?

StartupHub estimates Acrivon AB's annual revenue at $2.7M (range $714K to $4.8M, 27% confidence), based on comparable companies in the sector.

### What is Acrivon AB's valuation?

StartupHub estimates Acrivon AB's effective valuation at $36.3M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.

### How much funding has Acrivon AB raised?

Acrivon AB has raised a total of $10M in funding. The most recent round on record is Seed.

### Where is Acrivon AB headquartered?

Acrivon AB is headquartered in Uppsala, Sweden.

### When was Acrivon AB founded?

Acrivon AB was founded in 2022.

### What industry does Acrivon AB operate in?

Acrivon AB operates in AI Tools & Apps, AI Drug Discovery, Biotech, HealthTech, Foundation Model, Generative AI.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Acrivon AB",
          "item": "https://www.startuphub.ai/startups/acrivon-ab"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/acrivon-ab#webpage",
      "url": "https://www.startuphub.ai/startups/acrivon-ab",
      "name": "Acrivon AB - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Acrivon AB. Acrivon AB is a startup founded in 2022, operating in AI Tools & Apps and AI Drug Discovery. Acrivon AB develops targeted therapies for cancer patients by matching drug mechanisms to the biologic drivers of cancer using their proprietary AP3 platform. Headquartered in Uppsala, Sweden.",
      "dateModified": "2026-07-01T09:30:43.137864+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/acrivon-ab#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/acrivon-ab#organization",
      "name": "Acrivon AB",
      "url": "https://www.acrivon.com/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/b1f44211-8fae-4e60-a91a-727dbfd3ae00-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/b1f44211-8fae-4e60-a91a-727dbfd3ae00-square.webp",
      "description": "This is the official profile of Acrivon AB. Acrivon AB is a startup founded in 2022, operating in AI Tools & Apps and AI Drug Discovery. Acrivon AB develops targeted therapies for cancer patients by matching drug mechanisms to the biologic drivers of cancer using their proprietary AP3 platform. Headquartered in Uppsala, Sweden.",
      "sameAs": [
        "https://www.startuphub.ai/startups/acrivon-ab"
      ],
      "foundingDate": "2022-01-01",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Uppsala",
        "addressCountry": "Sweden"
      },
      "knowsAbout": [
        "AI Tools & Apps",
        "AI Drug Discovery",
        "Biotech",
        "HealthTech",
        "Foundation Model",
        "Generative AI",
        "Drug Discovery",
        "Therapeutics"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/acrivon-ab#profile-assessment",
      "name": "Acrivon AB - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/acrivon-ab",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/b1f44211-8fae-4e60-a91a-727dbfd3ae00-square.webp",
      "category": "AI Tools & Apps",
      "description": "This is the official profile of Acrivon AB. Acrivon AB is a startup founded in 2022, operating in AI Tools & Apps and AI Drug Discovery. Acrivon AB develops targeted therapies for cancer patients by matching drug mechanisms to the biologic drivers of cancer using their proprietary AP3 platform. Headquartered in Uppsala, Sweden. Agent Readiness score: 40/100. Full audit: https://www.startuphub.ai/startups/acrivon-ab/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "Acrivon AB"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-07-01",
        "name": "Acrivon AB - Profile Score 43/100",
        "reviewBody": "This is the official profile of Acrivon AB. Acrivon AB is a startup founded in 2022, operating in AI Tools & Apps and AI Drug Discovery. Acrivon AB develops targeted therapies for cancer patients by matching drug mechanisms to the biologic drivers of cancer using their proprietary AP3 platform. Headquartered in Uppsala, Sweden. Agent Readiness score: 40/100. Full audit: https://www.startuphub.ai/startups/acrivon-ab/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 43,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```